{"id":"https://openalex.org/W138375613","doi":null,"title":"When \"S\" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infection.","display_name":"When \"S\" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infection.","publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W138375613","mag":"138375613","pmid":"https://pubmed.ncbi.nlm.nih.gov/15926635"},"language":"en","primary_location":{"id":"pmid:15926635","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15926635","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Connecticut medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073843537","display_name":"Effie L. Gillespie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Effie L Gillespie","raw_affiliation_strings":["University of Connecticut, School of Pharmacy, Storrs, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Connecticut, School of Pharmacy, Storrs, USA","institution_ids":["https://openalex.org/I140172145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090657231","display_name":"Joseph L. Kuti","orcid":"https://orcid.org/0000-0002-4464-3126","observed_orcids":["https://orcid.org/0000-0002-4464-3126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph L Kuti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5090740872","display_name":"David P. Nicolau","orcid":"https://orcid.org/0000-0002-4148-0165","observed_orcids":["https://orcid.org/0000-0002-4148-0165"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David P Nicolau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1362,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.77590762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"69","issue":"4","first_page":"203","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.20810000598430634,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.8999999761581421},{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.675000011920929},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8799999952316284},{"id":"https://openalex.org/keywords/carbapenems","display_name":"carbapenems","score":0.9290000200271606},{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cefepime","display_name":"cefepime","score":0.9990000128746033},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.996999979019165},{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":1.0},{"id":"https://openalex.org/keywords/serious-bacterial-infection","display_name":"serious bacterial infection","score":0.5680000185966492},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.4959999918937683},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.837185263633728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7439263463020325},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.7372939586639404},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.639517068862915},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.6265502572059631},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.6090505719184875},{"id":"https://openalex.org/C2779181126","wikidata":"https://www.wikidata.org/wiki/Q5374236","display_name":"Empiric therapy","level":3,"score":0.5860768556594849},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5696156024932861},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5266953706741333},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5064104795455933},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.49235427379608154},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.4782620668411255},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4736187160015106},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.4405294358730316},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2725098133087158},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.22458842396736145},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10075300931930542},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.09993889927864075},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.08298376202583313},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.08079499006271362},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003657","descriptor_name":"Decision Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004352","descriptor_name":"Drug Resistance, Microbial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15926635","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15926635","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Connecticut medicine","raw_type":"Journal Article"},{"id":"mag:138375613","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15926635","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034302582","https://openalex.org/W2114807886","https://openalex.org/W2135807267","https://openalex.org/W1977116686","https://openalex.org/W2157825034","https://openalex.org/W2016744329","https://openalex.org/W2026301694","https://openalex.org/W2197827591","https://openalex.org/W2134516082","https://openalex.org/W2077731921"],"abstract_inverted_index":{"Antimicrobial":[0],"resistance":[1],"among":[2],"bacterial":[3],"pathogens":[4],"continues":[5],"to":[6,17,23,53],"challenge":[7],"clinicians.":[8],"It":[9],"is":[10,51],"the":[11,39,44,55,105],"main":[12],"reason":[13],"for":[14,80,92,108],"antibiotic":[15],"therapy":[16,103,121],"be":[18],"deemed":[19],"inappropriate":[20],"and":[21,26,83,94,115],"leads":[22],"unfavorable":[24],"outcomes":[25,114],"increased":[27],"costs.":[28],"Knowledge":[29],"of":[30,57,73,99,127],"local":[31],"susceptibility":[32,68,87],"patterns":[33],"can":[34],"help":[35],"clinicians":[36],"empirically":[37],"choose":[38],"appropriate":[40,100],"antibiotic.":[41],"In":[42],"addition,":[43],"proper":[45],"dosage":[46,78],"regimen,":[47],"based":[48],"on":[49],"pharmacodynamics,":[50],"essential":[52],"maximize":[54],"likelihood":[56,126],"achieving":[58],"optimal":[59],"therapy.":[60],"Pharmacodynamic":[61],"surveillance":[62],"studies":[63],"have":[64,123],"demonstrated":[65],"that":[66],"percent":[67,86],"provides":[69],"an":[70],"accurate":[71],"estimate":[72],"bactericidal":[74,90],"exposure":[75,91],"at":[76,104],"standard":[77],"regimens":[79],"carbapenems,":[81],"ceftazidime,":[82],"cefepime,":[84],"whereas":[85],"overestimates":[88],"actual":[89],"piperacillin/tazobactam":[93],"ciprofloxacin.":[95],"The":[96],"empiric":[97],"use":[98],"broad-spectrum":[101],"antimicrobial":[102],"correct":[106],"dosages":[107],"severe":[109],"infections":[110],"should":[111,122],"improve":[112],"clinical":[113],"result":[116],"in":[117],"economic":[118],"benefit.":[119],"Initial":[120],"a":[124],"high":[125],"covering":[128],"resistant":[129],"pathogens.":[130]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}